{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:36:58Z","timestamp":1784191018092,"version":"3.55.0"},"reference-count":47,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1586\/14760584.4.6.793","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T10:02:34Z","timestamp":1135245754000},"page":"793-805","source":"Crossref","is-referenced-by-count":21,"title":["A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and<i>Haemophilus influenzae<\/i>type b vaccine"],"prefix":"10.1586","volume":"4","author":[{"given":"Steven","family":"Black","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"CIT0001","first-page":"1","volume":"48","year":"1999","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"CIT0002","first-page":"1","volume":"31","year":"2005","journal-title":"Can. Commun. Dis. Rep."},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00241-7"},{"key":"CIT0004","unstructured":"Black S, Shinefield H; the 494\u201301\/00 Collaborative Investigators Group. Safety of DTaP\u2013IPV\/\/PRP-T (Pentacel\u2122) as compared to the administration of component vaccines in different injection sites. The 3rd Pediatric Infectious Disease Conference. Monterey, CA, USA. October 2001 (2001) (Abstract)."},{"key":"CIT0005","unstructured":"Blatter MM, Noriega F. Immunogenicity and safety of Pentacel\u2122 (diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine) in US infants 2, 4, and 6 months of age. The 11th International Congress on Infectious Diseases. Cancun, Mexico, March 2004 (2004)(Abstract)."},{"key":"CIT0006","unstructured":"Noriega F, Tomovici A, Jemiolo D, Greenberg DP, P3T06 study group. Safety and immunogenicity comparison of a fourth dose of DTaP\u2013IPV\/\/PRP-T (Pentacel\u2122) to the separate administration of Daptacel\u00aeand ActHIB\u00ae. The 43rdAnnual Meeting of the Infectious Diseases Society of America. San Francisco, USA. October, 2005. (2005) (Abstract No 985)."},{"key":"CIT0007","unstructured":"Noriega F, Tsang P, Jemiolo D, Voloshen T, Greenberg DP; the Pentacel Investigators Study Group. Immunogenicity of a four dose series of DTaP\u2013IPV\/\/PRP-T (Pentacel\u2122). The 5thPediatric Infectious Disease Conference. Napa, CA, USA. October, 2005. (2005)(Abstract No 9)."},{"key":"CIT0008","unstructured":"Herz A, Black S, Shinefield H, Noriega F, Greenberg D. Safety of Combined DTaP\u2013IPV + PRP-T (Pentacel\u2122) administered at 2, 4, 6, and 15 to 18 months of age. The Pediatric Academic Societies Annual Meeting. Washington DC, USA. May 2005. (2005)(Abstract No 1388)."},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200111001-00002"},{"key":"CIT0010","first-page":"Q1","volume":"53","year":"2004","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"CIT0011","first-page":"1041","volume":"53","year":"2004","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"CIT0012","first-page":"658","volume":"53","year":"2004","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1081-1206(10)61660-2","volume":"90","author":"Frenkel","year":"2003","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1185\/03007990152673837","volume":"17","author":"Vidor","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050797"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(99)04377-9","volume":"354","author":"Eskola","year":"1999","journal-title":"Lancet"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1086\/514741"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1086\/324007"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0891-5520(05)70276-2","volume":"15","author":"Edwards","year":"2001","journal-title":"Infect. Dis. Clin. North Am."},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(03)13171-6","volume":"361","author":"McVernon","year":"2003","journal-title":"Lancet"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000141743.74443.73"},{"key":"CIT0022","unstructured":"Gonzalez SN, Aguilar F, Barreto L, Muller C, Castaneda JL, Chavez R. A fully immunogenic pentavalent combination vaccine (DTaP-IPV and PRP-T). The 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, USA. September 1999. (1999) (Abstract No 238)."},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.1.25"},{"key":"CIT0024","first-page":"203","volume":"52","year":"2003","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"CIT0025","first-page":"1015","volume":"53","year":"2004","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1542\/peds.109.4.e58","volume":"109","author":"Zepp","year":"2002","journal-title":"Pediatrics"},{"key":"CIT0027","unstructured":"Pediarix Prescribing information, GlaxoSmithKline, August (2003)."},{"key":"CIT0028","volume":"57","author":"Thompson","year":"2005","journal-title":"Pediatr. Res."},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1086\/322562"},{"key":"CIT0030","unstructured":"Greenberg DP, Scheifele D, Noriega F. Immunogenicity of Pentacel\u2122 when administered as a fourth dose at 15 to 18 months of age. The Pediatric Academic Societies\u2019 Annual Meeting. San Francisco, CA, USA. May 2004. (2004)(Abstract LB18)."},{"key":"CIT0031","unstructured":"Edwards KM, Tsang P, Wang, L, and Noriega, F for the M5A03 Study Group. Safety and Immunogenicity of DTaP-IPV\/\/PRP-T (Pentacel\u2122) Coadministered with Pneumococcal Conjugate Vaccine (Prevnar\u00ae) at 2, 4, and 6 months of age. The 43rdAnnual Meeting of the Infectious Diseases Society of America. San Francisco, USA, October, 2005. (2005)(Abstract No 984)."},{"key":"CIT0032","unstructured":"Noriega F, Greenberg DP, Tsang PHet al. Effect of pneumococcal conjugate vaccine (PCV-7) on antibody responses to concomitantly administered Pentacel\u2122 (DTaP-IPV\/\/PRP-T) or licensed equivalent vaccines. The 43rdAnnual Meeting of Infectious Diseases Society of America. San Francisco, USA, October, 2005 (2005)(Abstract No 981)."},{"key":"CIT0033","first-page":"243","volume":"25","author":"Halperin","year":"2002","journal-title":"Clin. Invest. Med."},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200205000-00010"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2165\/00003495-200565100-00005","volume":"65","author":"Casey","year":"2005","journal-title":"Drugs"},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1542\/peds.112.6.e453","volume":"112","author":"Skowronski","year":"2003","journal-title":"Pediatrics"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1542\/peds.112.5.e348","volume":"112","author":"Le Saux","year":"2003","journal-title":"Pediatrics"},{"key":"CIT0041","unstructured":"Skowronski DM, Patrick DM, Naus M et al. Survey for Serious Adverse Events (SAEs) Following Immunization with the 4thdose of a diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b Combination Vaccine (DTaP-IPV\/\/PRP-T, Pentacel\u2122) in British Columbia (BC), Canada. The 43rdAnnual Meeting of the Infectious Diseases Society of America. San Francisco, USA. October, 2005. (2005)(Abstract No 988)."},{"key":"CIT0042","first-page":"93","volume":"26","author":"Scheifele","year":"2000","journal-title":"Can. Commun. Dis. Rep."},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1031861"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1086\/340280"},{"key":"CIT0045","unstructured":"Kandola K, Lea A, White W, Santos M. A comparison of pertussis rates in Northwest Territories: pre-and post-acellular pertussis vaccine introduction in children and adolescents. The 6th Canadian Immunization Conference. Montreal, Quebec, Canada. December (2004)."},{"key":"CIT0046","first-page":"1","volume":"29","year":"2003","journal-title":"Can. Commun. Dis. Rep."},{"key":"CIT0047","unstructured":"Bettinger J, Halperin S, De Serres G, Scheifele D, IMPACT Investigators. Epidemiology of hospitalized pertussis after change from whole-cell to acellular pertussis vaccine. The Canadian Immunization Conference. Montreal, Quebec, Canada. December (2004)."}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14760584.4.6.793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:34:18Z","timestamp":1555029258000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14760584.4.6.793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,1,9]]},"published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1586\/14760584.4.6.793"],"URL":"https:\/\/doi.org\/10.1586\/14760584.4.6.793","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}